Wondfo Biotech to maintain convertible bond price despite trigger

Guangzhou Wondfo Biotech Co., Ltd. announced on October 21, 2025, that its board of directors has decided not to amend downwards the conversion price of its "Welfull Convertible Bonds." The company's stock had triggered the downward revision clause after its closing price fell below 80% of the current conversion price for at least fifteen trading days within any consecutive thirty trading days. The current conversion price of the "Welfull Convertible Bonds" stands at 27.00 yuan per share, effective from September 17, 2025.

The board's decision was made after considering the company’s current situation, stock price trends, market environment, and confidence in its long-term stable development and intrinsic value. This decision not to amend downwards will be effective for the next three months, from October 22, 2025, to January 21, 2026.

During this three-month period, if the downward revision clause is triggered again, the company will not propose a downward amendment. Starting January 22, 2026, if the clause is triggered again, the board will convene a meeting to reconsider exercising its right to amend the conversion price downwards.